AzTrials
AzTrials

Sleep Initiation and Maintenance DisordersETP-INSOMNIENCT05000528

Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia

A study testing therapeutic education and Actimetry in people with Sleep Initiation and Maintenance Disorders, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

20 to 30% of the general population suffers from chronic insomnia. Cognitive behavioral therapy (CBT) is the first-line treatment, but unfortunately its implementation is complex. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
therapeutic education and Actimetry
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
1 siteFrance
Study dates
30 Sep 2022to 29 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The patient must have given their free and informed consent
  • The patient must be a member or beneficiary of a health insurance plan
  • Patient must understand and read French
  • Patient with ICSD-3 diagnostic criteria for chronic insomnia: ISI score > 14/28.

Who cannot join

  • Patient with cognitive impairment as assessed by the investigator
  • Patient with shift work
  • Patients scoring > 10/24 on the Epworth sleepiness scale
  • Patient suffering from medical or psychiatric illnesses which may, in the opinion of the investigator, compromise the subject's state of health or ability to participate in the study.
  • Patient with chronic alcohol consumption or drug abuse
  • Patient unable to express consent.
Show all 10Show fewer
  • Pregnant, parturient or breastfeeding patient.
  • The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de NIMES

    Nîmes, 30029

Other trials in France

About this study

Official title: Etude Pilote d'évaluation de l'efficacité de l'ETP Sur l'Insomnie Chronique

20 to 30% of the general population suffers from chronic insomnia. Cognitive behavioral therapy (CBT) is the first-line treatment, but unfortunately its implementation is complex. Long waiting times for a consultation / exploration, too short a consultation period, non-reimbursement of specialists and a lack of trained staff make the current care of insomniac patients difficult. Patients are thus treated late, often with heavy drug treatment, dependence on sleeping pills, difficult withdrawal and / or reactive mood disorders. The treatment is therefore limited to advice on sleep hygiene and a restriction of time spent in bed without ultimately intervening in the cognitive domain. Therapeutic education consists of empowering the patient in the management of chronic insomnia through group education workshops. The patient learns the principles of normal sleep, the way in which sleep evolves with aging, the dangers of treatments as well as the rules of sleep hygiene and the behaviors to modify to sleep well. In addition to benefiting from sharing of experience with other patients, therapeutic education makes the care pathway smoother and considerably reduces the long waiting times of the traditional care pathway in consultation.

The study investigators hypothesize that therapeutic education is more effective as a treatment for chronic insomnia than traditional management in individualized consultation (IC). Thus, therapeutic education could constitute an effective alternative to CBT.

Being tested
therapeutic education, Actimetry
Medical subject headings
Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • therapeutic educationOther

    In groups of 5-6, patients will have a one-day therapeutic training session comprising 4 workshops: how to create a sleep agenda; normal sleep; sleep hygiene; medical treatments.

  • ActimetryOther

    once from inclusion for 2 weeks, second for 2 weeks starting 2 weeks after intervention

Study groups in NCT05000528
Study groupRoleWhat they receive
Therapeutic educationExperimentalNot described
Receives: Other: therapeutic education; Other: Actimetry
Individualized consultationActive comparatorNot described
Receives: Other: Actimetry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improvement in chronic insomnia between groups

    Change in Insomnia Severity Index (ISI) score (Score between 0 - 28) from inclusion

    Measured: Day 28

Secondary outcomes (20)
  1. Change in total sleeping time between groups

    Change in total sleeping time (minutes) from inclusion

    Measured: Day 28

  2. Change in time in bed between groups

    Change in time in bed (minutes) from inclusion

    Measured: Day 28

  3. Change in effective sleep

    Time between going to bed and falling asleep (minutes). Average time for the 2 weeks following inclusion versus the 2 weeks preceding the study end measured by actimetry bracelet

    Measured: Day 28

  4. Change in sleep latency

    % total sleeping time / time in bed. Average time for the 2 weeks following inclusion versus the 2 weeks preceding the study end measured by actimetry bracelet

    Measured: Day 28

  5. Change in intra-sleep time

    Change in time between going to bed and falling asleep (minutes) since inclusion, data collected from patient sleep agenda

    Measured: Day 28

  6. Change in anxiety since baseline between groups

    State-Trait Anxiety Inventory (STAI-Y). Self-questionnaire assessing anxiety-status (AE) reflecting the current emotional state and anxiety-trait (AT) reflecting the usual emotional state. Total score 20-80.

    Measured: Day 28

  7. Change in depression since baseline between groups

    Beck Depression Inventory (BDI). The total score is obtained by adding the scores of the 13 items. This score will be between 0 and 63. The higher the score, the more depressed the subject is.

    Measured: Day 28

  8. Change in quality of life since baseline

    Dysfunctional Beliefs and Attitudes about Sleep - 16 (DBAS-16). This self-questionnaire is composed of 16 items: Perceived consequences of insomnia (5 items), Worry/impotence about insomnia (6 items), Sleep expectations (2 items), Medication (3 items). The global score is an average of the scores of each item, ranging from 0 to 10. The higher the score, the more dysfunctional beliefs and attitudes about sleep

    Measured: Day 28

  9. Use of hypnotic drugs between groups

    Yes/no for each type

    Measured: Day 28

  10. Use of anxiolytic drugs between groups

    Yes/no for each type

    Measured: Day 28

  11. Dose of any hypnotic drugs taken between groups

    Measured: Day 28

  12. Dose of any anxiolytic drugs taken between groups

    Measured: Day 28

  13. Completion of therapeutic education sessions of patients in the therapeutic education group

    Yes/no

    Measured: Day 28

  14. Length of workshops in the therapeutic education group

    Minutes

    Measured: Day 28

  15. Problems encountered during workshops of patients in the therapeutic education group

    Descriptive list made by investigator

    Measured: Day 28

  16. Patient-reported reason for refusal to participate in the therapeutic education group

    Descriptive list of reasons given by the patient

    Measured: Day 28

  17. Improvement in chronic insomnia between groups

    Change in Insomnia Severity Index (ISI) score (Score between 0 - 28) from inclusion

    Measured: Month 4

  18. Change in anxiety since baseline between groups

    State-Trait Anxiety Inventory (STAI-Y). Self-questionnaire assessing anxiety-status (AE)

    Measured: Month 4

  19. Change in depression since baseline between groups

    Beck Depression Inventory (BDI). The total score is obtained by adding the scores of the 13 items. This score will be between 0 and 63. The higher the score, the more depressed the subject is.

    Measured: Month 4

  20. Change in quality of life since baseline

    Dysfunctional Beliefs and Attitudes about Sleep - 16 (DBAS-16). This self-questionnaire is composed of 16 items: Perceived consequences of insomnia (5 items), Worry/impotence about insomnia (6 items), Sleep expectations (2 items), Medication (3 items). The global score is an average of the scores of each item, ranging from 0 to 10. The higher the score, the more dysfunctional beliefs and attitudes about sleep

    Measured: Month 4

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2021
  2. Study start30 Sep 2022
  3. Primary completion30 Mar 2024
  4. Study completion29 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05000528
Sponsor's protocol ID
NIMAO/2020-2/BA-1
Acronym
ETP-INSOMNIE
Status last verified
Oct 2026
First submitted
22 Jul 2021
Last updated
21 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing therapeutic education and Actimetry in people with Sleep Initiation and Maintenance Disorders, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improvement in chronic insomnia between groups (time frame: Day 28). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in